Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TRIPLING the O/S not on the bullet points at any time over the last year to the "Team".
????Team Tsunami????
Brief overview for those that are new.
-Audited financials since 2014, very rare for an OTC
-Open & transparent CEO
-Stated objective is to be ACQUIRED (RESMED has history of buyouts near 500 million)
-Management has over 40 yrs combined experience
-CEO has over 19 patents in the sleep apnea field
- DeltaWave’s unique patented design delivers 14 breaths/min, most others are around 9
-DeltaWave is the first mask that will treat patients with COPD & Congestive Heart Failure
Recent and future catalyst's
1. PR- CONDENSATION TESTS (1.5.22)?
2. PR- Investor Relations Firm Hired (1.24.22) ?
3. CPAP Distribution Agreement (3.22.22) ?
4. Completed/Successfully Passed Cytox Test (4.22.22) ?
5. CPAP Machine Update 33% increase in month two (4.27.22)?
6. PR- FDA AI Response (5.6.22)?
7. 510K APPROVAL (Est. June 6-16)
8. Uplisting to OTCQB - in Progress (PR Anyday)
9. Revenue/Profit Update Cpap Machine
9. Apply for CE mark for DeltaWave
I didn’t realize a ceo needed to explain to people how he is running the company… especially when his company’s stock has made share holders money.
In 16 months the stock price is up over 2000%….. remsleep was a pre revenue company so yes there was always going to be some dilution.
Not sure why you are complaining about the stock price continuing to grow.
The 510k process will be completed in under a month.
$50million marketcap and still NO FDA 510K
Not a word to the "Team" that this is what was happening to the company in the span of only one year.
Not ONE mention of convertible notes until they were mostly converted.
Since the date of your picture RMSL is up over 50%
2000% ROI to an investor who got in 16 months ago… the only thing this company is bank rolling is retail investors who get in early.
I get your point there! believe me I owned 10% of the float at one time here when it was 6M so I understand. The product is good though - I test it every night.
He paid all of ZERO$ for those shares.
Tom had the opportunity to protect shareholders from the dilution from convertible notes which are 10x worse than an offering.
The “inventor” is ceo and owns approx 25 million shares… so dilution and stock sales actually hurt the paycheck of the inventor. ???????
Selling stock? You mean the reg A offering that was actually closed early? The offering that was used to have cash on hand for FDA process and production. The offering that has allowed them to build an effective marketing strategy once approved?
There has been no new “debt” in a long time and in fact their debt on the list 10q showed it was significantly paid down and almost paid off…
You are welcome to join the real world anytime
And now they are at the final stage of approval for that 510k… you are making a bullish case to want to buy in right now.
"Glue?" Nope. The pads have a medical non-irritating adhesive. Takes about a minute to put them on. They are unique because there's no headgear.
But the point was that mask went zero to market in 4-5 years and without selling $10M worth of stock to pay the "inventor." Only thing this company is selling is stock.
Really? gluing pads to your face everynight, SMH! That wouldn't last a week for me. Go for it! GLTU
So what if it did pass FDA approval? It's one mask, horribly designed, likely uncomfortable, entering a market flooded with better masks from real companies. This company has been selling stock and taking on toxic loans to pay themselves handsomely while they piddled with this one thing, and it won't sell.
Meanwhile, here's how you do a mask:
https://bleepsleep.com/the-eclipse/
4 years from concept to the market later this summer with private investment that is dwarfed by this company's loans and stock sales.
and now they resubmitted after resolving the cytotoxicity issues. So, wrapping everything up, why are you bearish? why do you think it will not pass fda approval this time around?
510k submitted 7/15/21:
6/1/21 PR: they hired Empirical:
https://www.globenewswire.com/en/news-release/2021/06/02/2240023/0/en/REMSleep-510K.html
7/15/21 They submitted the 510k
https://www.globenewswire.com/en/news-release/2021/07/15/2263714/0/en/REMSleep-510K-Submission.html
do you have literature where it says empirical was overseeing the 2021 submission? the PR is from June 2021 and it says they had grown frustrated and now partnered with them to complete the 510k submission, which i would think is the 2022 submission.....
2021 submission was straight up with Empirical. There's another PR in 2021 that gives the 510K submission number with Empirical.
"Beating around the bush" is a very polite way of describing the violations of fiduciary duty the CEO has to disclose material events to shareholders in a timely manner.
It all comes down to credibility.
the 2021 submission was not with empirical though. the 2022 submission was with empirical. and though they were beating around the bush with the cytotoxicity reports/labs etc, they wouldn't have resubmitted if that issue wasnt resolved. Again, not trying to go against you, just trying to understand the pessimism, i just want to make some money. seems to me like they are trying to move on from their unsteady past, maybe this submission will do that.....we shall see....hypothetically, if the submission passes, where do you see the SP going? and if it fails, obviously it will dump
Facts are you would have made good money.
#Don'tLetFacts get in the way of the pump right?
2021 was the submission. 2022 was a Re-submission of the 510k.
They had to resubmit the 510k because they failed two cytotoxicity tests which would have resulted in another rejection of the 510k. They told shareholders it was just a procedural issue with the test and they hired a toxicologist to correct the procedures and then failed the cytotoxicity test again. Then they blamed it on the lab and used a different lab to pass the test.
wouldn't they not have been able to submit the 510k if they didn't resolve this issue?
the submission that was just submitted on the 6th was with Empirical, they partnered with them in 2021 and completed the submission in 2022, is that bad? i mean, i would want them to get their shit together before submitting again and being rejected. IDC how long it takes if its more likely to guarantee an approval
i understand your frustration and the background neglect from the management to update shareholders etc....but what happens when/if they get FDA approval, then they have a niche product with a huge marketplace, isn't that worth betting on?
The "orders" are for third party cpap machines. They can't sell the DeltaWave until the 510k is cleared by the FDA. The company is currently valued at over $50 million dollars which is ABSURD when the same third party cpap machines are a dime a dozen all over the internet.
correct, just mentioned that in my last reply, empirical is definitely reassuring
still going back over 2 years ago, has any management changed since then? partnering with empirical tech for their submission seems reassuring. they have a great track record. still seems like a low risk/high reward play to me
Let’s not forget they brought in a company with 100% track record of getting 510k’s approved.
I mean, it gives some context and background, but, two years later and a newly submitted 510k, you don't think any kinks were worked out? still seems its just a matter of time. they have actual orders dont they? anything in OTC is speculation and a pipedream but i think the fundamentals are still in play as long as the management is transparent
Insane dilution, three-card monte CEO played with the 510k, shady antics with the Twitter account: CEO claimed their original Twitter account that was used to pump the stock so noteholders could dump was fake. They deleted it and started a new account....
https://www.globenewswire.com/news-release/2020/01/27/1975547/0/en/REMSleep-Holdings-Inc-Issues-Statement-Clarifying-Unauthorized-Twitter-Post-and-Account.html
Great factual post… so glad you have been able to show us the process of a 510k approval. With the continued 52 week highs anybody that listened to your posts would have missed out on profit!
You were bullish back in 2019-2020, whats changed with the company or device for you to become so bearish? the amount of time its taken for the PMA 510k?
hell yea scooping more today
FDA approval next week!!!
Loaded up some more here in the low .03s. I think the chart will turn up tomorrow. MMs will likely keep it down here for the rest of the day.
It's certainly possible given the huge amount of pre FDA approval accumulation we have seen these past few weeks.
Did Big Momma hear 10 cents in the near future?
Followers
|
309
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
31338
|
Created
|
11/14/08
|
Type
|
Free
|
Moderators |
REMSleep Holdings, Inc. is engaged in the business of developing and distributing sleep apnea products. The Company focuses on offering optimum compliance and comfort for continuous positive airway pressure (CPAP) patients. Its DeltaWave CPAP interface (the DeltaWave) is a device to treat patients with sleep apnea. Its DeltaWave product is a nasal-pillows type interface that is designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Its product is manufactured by mold makers. Its target market includes home care dealers, private sleep labs, product end users, sleep physicians, medical groups, sleep product distributors, hospitals, medical associations, such as the American academy of sleep medicine and the American sleep association. REMSleep LLC is its wholly owned subsidiary.
INDUSTRY
Medical Equipment & Supplies
CONTACT INFO
2202 N. WEST SHORE BLVD SUITE 200
TAMPA, FL
33607
United States
+1.912.5902001
https://www.remsleep.com/EXECUTIVE LEADERSHIP
Russell Finlay Bird
Chairman of the Board
Thomas J. Wood
Chief Executive Officer, Director
Jonathan B Lane
Chief Technology Officer, Vice President
https://www.fundable.com/remsleep
Share Structure
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |